Toshiki Terao, Yoshiaki Abe, Ayumi Kuzume, Rikako Tabata, Takafumi Tsushima, Hiroki Kobayashi, Daisuke Miura, Akihiro Kitadate, Kentaro Narita, Masami Takeuchi, Kosei Matsue (Division of Hematology/Oncology, Kameda Medical Center, Chiba, Japan)
Session information
Oral Session
Oral Session 3-11A Multiple Myeloma: Related Disorders
Sun. Oct 13, 2019 9:00 AM - 10:00 AM No.11 (Tokyo International Forum, 5F G502)
Chair: Emiko Sakaida (Department of Hematology, Chiba University Hospital)
Satoko Oka1, Kazuo Ono2, Hiroshi Shiragami1, Yayoi Shimazu1, Yutaka Shimazu1, Masaharu Nohgawa1 (1.Hematology, Wakayama Medical Center, Japan, 2.Pathology, Wakayama Medical Center, Japan)
Asuka Shibamiya1, Chikako Ohwada1, Shinichiro Matsui1, Sanshiro Nakao1, Arata Ishii1, Yurie Nagai1, Tatsuzo Mishina1, Miki Yamazaki1, Yusuke Isshiki1, Koji Takaishi1, Kenji Kimura1, Nagisa Oshima1, Shokichi Tsukamoto1, Yusuke Takeda1, Shio Mitsukawa1,2, Naoya Mimura1,2, Masahiro Takeuchi1, Tohru Iseki1,2, Sonoko Misawa3, Satoshi Kuwabara3, Chiaki Nakaseko1,4, Emiko Sakaida1 (1.Department of Hematology, Chiba University Hospital, 2.Department of Blood Transfusion and Cell Therapy, Chiba University Hospital, 3.Department of Neurology, Chiba University Graduate School of Medicine, 4.Department of Hematology, International University of Health and Welfare)
Tomoyuki Sakamoto, Itoko Okuda, Yu Akuzawa, Yoshihiro Ito, Naoki Wakimoto, Yumiko Uchida, Shigehisa Mori, Masami Bessho, Yuichi Nakamura (Hematol., Saitama Medical Univ. Hosp., Saitama, Japan)
Kenji Kimura1, Shokichi Tsukamoto1, Kanji Miyazaki2, Chika Manako3, Rahmutulla Bahityar4, Masaki Fukuyo4, Nagisa Oshima1, Shio Mitsukawa1,5, Yusuke Takeda1, Naoya Mimura1,5, Masahiro Takeuchi1, Chikako Ohwada1, Tohru Iseki1,5, Keisuke Matsusaka4, Atsushi Kaneda4, Tadao Ishida2, Kenshi Suzuki2, Chiaki Nakaseko1,6, Emiko Sakaida1 (1.Department of Hematology, Chiba University Hospital, Chiba, Japan, 2.Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan, 3.Department of Hematology, Oami Municipal Hospital, Chiba, Japan, 4.Department of Molecular Oncology, Chiba University Graduate School of Medicine, 5.Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, 6.Department of Hematology, International University of Health and Welfare)
Shinichi Fuchida1, Daisuke Ide1, Yoko Taminishi1,2, Saori Matsui1, Akira Okano1,3, Mayumi Hatsuse1, Satoshi Murakami1, Chihiro Shimazaki1 (1.Department of Hematology, JCHO Kyoto Kuramaguchi Medical Center, 2.Department of Hematology, Kyoto Prefectural University of Medicine, 3.Department of Hematology, Omihachiman Community Medical Center)